233 related articles for article (PubMed ID: 34784656)
1. Thromboembolism and bleeding in systemic amyloidosis: a review.
Nicol M; Siguret V; Vergaro G; Aimo A; Emdin M; Dillinger JG; Baudet M; Cohen-Solal A; Villesuzanne C; Harel S; Royer B; Arnulf B; Logeart D
ESC Heart Fail; 2022 Feb; 9(1):11-20. PubMed ID: 34784656
[TBL] [Abstract][Full Text] [Related]
2. Atrial Fibrillation, Thromboembolic Risk, and Anticoagulation in Cardiac Amyloidosis: A Review.
Bukhari S; Khan SZ; Bashir Z
J Card Fail; 2023 Jan; 29(1):76-86. PubMed ID: 36122817
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic and bleeding complications in patients with AL amyloidosis.
Fotiou D; Theodorakakou F; Spiliopoulou S; Gavriatopoulou M; Migkou M; Kanellias N; Eleutherakis-Papaiakovou E; Malandrakis P; Dialoupi I; Roussou M; Ntanasis-Stathopoulos I; Terpos E; Dimopoulos MA; Kastritis E
Br J Haematol; 2024 May; 204(5):1816-1824. PubMed ID: 38321638
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Amyloidosis Presenting with Pre-Excitation Syndrome, Heart Failure, and Severe Factor X Deficiency as Part of Systemic Amyloid Light-Chain (AL) Amyloidosis - A Fatal Combination.
Almasri H; Almeer A; Awouda S; Hamid O; Sardar S; Anwer Z; Ibrahim F; Soliman D; Kandathil Y; Abu-Tineh M; Alabdul Razzak I; Alazawi SH
Am J Case Rep; 2021 Aug; 22():e933398. PubMed ID: 34413281
[TBL] [Abstract][Full Text] [Related]
5. Repeated systemic thromboembolism in a patient with severe cardiac AL amyloidosis without evidence of atrial fibrillation.
Cappelli F; Padeletti L; Acquafresca M; Pignone AM; Perfetto F
Intern Emerg Med; 2014 Mar; 9(2):243-5. PubMed ID: 23712555
[No Abstract] [Full Text] [Related]
6. Serum Free Light Chain Difference and β
Park H; Kim JW; Youk J; Koh Y; Lee JO; Kim KH; Bang SM; Kim I; Park S; Yoon SS
Clin Lymphoma Myeloma Leuk; 2018 Jun; 18(6):408-414. PubMed ID: 29625928
[TBL] [Abstract][Full Text] [Related]
7. [Cardiac amyloidosis - important differential diagnosis in heart failure].
Morbach C; Steinhardt M; Störk S
Dtsch Med Wochenschr; 2022 Nov; 147(23):1522-1530. PubMed ID: 36384153
[TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role.
Longhi S; Quarta CC; Milandri A; Lorenzini M; Gagliardi C; Manuzzi L; Bacchi-Reggiani ML; Leone O; Ferlini A; Russo A; Gallelli I; Rapezzi C
Amyloid; 2015; 22(3):147-55. PubMed ID: 25997105
[TBL] [Abstract][Full Text] [Related]
9. Cardiac involvement in heavy and light chain amyloidosis: A case report and literature review.
Otaka Y; Nakazato Y; Tsutsui T; Tamura J
Medicine (Baltimore); 2019 Nov; 98(46):e17999. PubMed ID: 31725668
[TBL] [Abstract][Full Text] [Related]
10. Systemic light-chain amyloidosis presenting with rapid progressive heart failure.
Sunbul M; Durmus E; Kivrak T; Besiroglu F; Gerin F; Sari I; Mutlu B
Ther Adv Cardiovasc Dis; 2013 Aug; 7(4):224-7. PubMed ID: 23868674
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.
Mancio Silva J; Fontes-Carvalho R; Valente D; Almeida C; Cruz AJ; Tente D; Coelho H; Oliveira M; Albuquerque A; Ribeiro VG
Am J Case Rep; 2015 Mar; 16():174-81. PubMed ID: 25803181
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Care of Patients with Cardiac Amyloidosis.
Itzhaki Ben Zadok O; Kornowski R
Acta Haematol; 2020; 143(4):343-351. PubMed ID: 32408301
[TBL] [Abstract][Full Text] [Related]
13. Systemic light chain amyloidosis myopathy responsive to daratumumab monotherapy.
Chitimus DM; Berling E; Garderet L; Venturelli N; Malfatti E; Authier FJ; Nicolas G; Laforêt P; Lefeuvre C
Eur J Neurol; 2023 Mar; 30(3):745-748. PubMed ID: 36403110
[TBL] [Abstract][Full Text] [Related]
14. Peripheral Nervous, Hepatic, and Gastrointestinal Endpoints for AL Amyloidosis Clinical Trials: Report from the Amyloidosis Forum Multi-organ System Working Group.
Mauermann ML; Clarke JO; Litchy WJ; Obici L; Lousada I; Gertz MA;
Adv Ther; 2023 Nov; 40(11):4695-4710. PubMed ID: 37658177
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin Light Chain Amyloidosis Presenting as Inferior Vena Cava Thrombosis.
Axentiev A; Rozik M; Slama E; Setya V
Am Surg; 2023 Jun; 89(6):2788-2790. PubMed ID: 34743583
[TBL] [Abstract][Full Text] [Related]
16. Eyes on amyloidosis: microvascular retinal dysfunction in cardiac amyloidosis.
Zampiccoli E; Barthelmes J; Kreysing L; Nägele MP; Nebunu D; Haider T; von Eckardstein A; Gerber B; Schwotzer R; Ruschitzka F; Sudano I; Flammer AJ
ESC Heart Fail; 2022 Apr; 9(2):1186-1194. PubMed ID: 35060356
[TBL] [Abstract][Full Text] [Related]
17. Al amyloidosis.
Desport E; Bridoux F; Sirac C; Delbes S; Bender S; Fernandez B; Quellard N; Lacombe C; Goujon JM; Lavergne D; Abraham J; Touchard G; Fermand JP; Jaccard A;
Orphanet J Rare Dis; 2012 Aug; 7():54. PubMed ID: 22909024
[TBL] [Abstract][Full Text] [Related]
18. Thromboembolic and bleeding risk in cardiac amyloidosis.
Tana M; Tana C; Rossi D; Mantini C; Gallina S; Ricci F; Porreca E
J Thromb Haemost; 2024 May; ():. PubMed ID: 38810701
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology, Mechanisms, and Management of Atrial Fibrillation in Cardiac Amyloidosis.
Bukhari S; Oliveros E; Parekh H; Farmakis D
Curr Probl Cardiol; 2023 Apr; 48(4):101571. PubMed ID: 36584731
[TBL] [Abstract][Full Text] [Related]
20. Muscle involvement with pseudohypertrophy in systemic light chain amyloidosis: Case report.
Draghici M; Jercan A; Badelita SN; Irimia RM; Bastian AE; Dobrea C; Popescu M; Coriu D
Medicine (Baltimore); 2021 Dec; 100(51):e28267. PubMed ID: 34941106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
